Publicaciones en colaboración con investigadores/as de Indiana University School of Medicine - Lafayette (28)

2024

  1. Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure

    Annals of Clinical and Translational Neurology, Vol. 11, Núm. 6, pp. 1541-1556

  2. Enhanced quantitation of pathological α-synuclein in patient biospecimens by RT-QuIC seed amplification assays

    PLoS Pathogens, Vol. 20, Núm. 9

  3. Framework for Research Gaps in Pediatric Ventilator Liberation

    Chest, Vol. 166, Núm. 5, pp. 1056-1070

  4. The Human Phenotype Ontology in 2024: phenotypes around the world

    Nucleic acids research, Vol. 52, Núm. D1, pp. D1333-D1346

2023

  1. A Network Meta-analysis of Dexamethasone for Preventing Postextubation Upper Airway Obstruction in Children

    Annals of the American Thoracic Society, Vol. 20, Núm. 1, pp. 118-130

  2. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

    Movement Disorders, Vol. 38, Núm. 2, pp. 286-303

  3. Executive Summary: International Clinical Practice Guidelines for Pediatric Ventilator Liberation, A Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network Document

    American Journal of Respiratory and Critical Care Medicine, Vol. 207, Núm. 1, pp. 17-28

  4. Metastatic solid tumors to the testis: a clinicopathologic evaluation of 157 cases from an international collaboration

    Human Pathology, Vol. 139, pp. 37-46

  5. Metastatic solid tumours to the penis: a clinicopathologic evaluation of 109 cases from an international collaboration

    Histopathology, Vol. 83, Núm. 1, pp. 31-39

  6. Operational Definitions Related to Pediatric Ventilator Liberation

    Chest, Vol. 163, Núm. 5, pp. 1130-1143

2022

  1. Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

    npj Parkinson's Disease, Vol. 8, Núm. 1

  2. Temporal order of clinical and biomarker changes in familial frontotemporal dementia

    Nature medicine, Vol. 28, Núm. 10, pp. 2194-2206

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 1, pp. 216-225.e5

  2. Early use of adjunctive therapies for pediatric acute respiratory distress syndrome: A pardie study

    American Journal of Respiratory and Critical Care Medicine, Vol. 201, Núm. 11, pp. 1389-1397

  3. Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients

    Annals of Clinical and Translational Neurology, Vol. 7, Núm. 10, pp. 1816-1830

2019

  1. Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls

    Movement Disorders, Vol. 34, Núm. 9, pp. 1392-1398

2018

  1. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

    The Lancet Neurology, Vol. 17, Núm. 6, pp. 548-558

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222